Specializing in Drug Development and Pharmacokinetics\Pharmacodynamics

•Global Preclinical and Clinical Strategic and   Operational Development Plans, Protocols              and Final Reports

 

•Regulatory Submissions (e.g. INDs, NDAs,       SNDAs) and Interactions with various                     agencies (US, Europe and Japan)

 

•Manuscripts

 

•Due Diligence Reviews